Top compounds associated with response to NDE1


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin GDSC1000 pan-cancer AAC -0.071 0.07
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.067 0.07
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.07
mRNA BRD-K17060750 CTRPv2 pan-cancer AAC 0.068 0.07
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.068 0.07
mRNA PLX4720 CCLE pan-cancer AAC 0.084 0.07
mRNA tacrolimus CTRPv2 pan-cancer AAC -0.063 0.07
mRNA Nilotinib GDSC1000 pan-cancer AAC -0.071 0.07
mRNA KU-55933 GDSC1000 pan-cancer AAC -0.069 0.07
mRNA Docetaxel CTRPv2 pan-cancer AAC -0.088 0.07
Download CSV